Taurine

Taurine

SCHEMBL30179154

N[13CH2][13CH2]S(=O)(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Taurine SCHEMBL30191395 1.00
Taurine SCHEMBL42632 1.00 BLM (1.00)
Taurine SCHEMBL23068 1.00
Taurine SCHEMBL8052521 0.97 BLM (0.93)
Taurine SCHEMBL923628 0.97
Taurine SCHEMBL466027 0.97
Taurine SCHEMBL19438470 0.97
Taurine SCHEMBL3667691 0.97
Taurine SCHEMBL10952596 0.97
Taurine SCHEMBL1100954 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4133266-A1 IMPROVED METHODS FOR EVALUATING LIVER FUNCTION Hepquant, LLC (US) 2023-02-15 EP claimed
CN-119028455-B Use of metabolites in prediction of immune reconstitution outcome after antiretroviral therapy of HIV-infected persons 中国人民解放军总医院第五医学中心 2025-05-16 CN disclosed
CN-119028455-A Use of metabolites in prediction of immune reconstitution outcome after antiretroviral therapy of HIV-infected persons 中国人民解放军总医院第五医学中心 2024-11-26 CN disclosed
EP-4133266-A1 IMPROVED METHODS FOR EVALUATING LIVER FUNCTION Hepquant, LLC (US) 2023-02-15 EP disclosed